Bacteriophage therapy as a treatment option for complex cardiovascular implant infection: The German Heart Center Berlin experience
- PMID: 35183435
- DOI: 10.1016/j.healun.2022.01.018
Bacteriophage therapy as a treatment option for complex cardiovascular implant infection: The German Heart Center Berlin experience
Abstract
Conventional antimicrobials have low or no activity against multidrug-resistant or chronic implant-associated infections. Lytic bacteriophages can rapidly and selectively kill bacteria, and can be combined with antibiotics. However, clinical experience of bacteriophage therapy in patients with cardiovascular infections is limited. We documented the outcome and safety of intravenous and local adjunctive bacteriophage therapy, to treat chronic relapsing cardiovascular implant infections at our institution.
Keywords: alternative therapy; bacteriophage therapy; biofilm infections; cardiovascular implant infections; multidrug resistant infections.
Copyright © 2022 International Society for Heart and Lung Transplantation. Published by Elsevier Inc. All rights reserved.
Conflict of interest statement
Disclosure statement The authors have no conflicts of interest to declare.
Comment in
-
Bacteriophage therapy and the biofilm: An old solution for a persistent and desperate problem?J Heart Lung Transplant. 2022 May;41(5):556-557. doi: 10.1016/j.healun.2022.02.007. Epub 2022 Feb 15. J Heart Lung Transplant. 2022. PMID: 35283053 No abstract available.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources